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It is well known that the biological effectiveness of a 
certain absorbed dose of ionizing radiation depends on the 
radiation quality, i. e. the spectrum of ionizing particles and 
their energy distribution [1], [2], [3]. As has been shown in 
several studies, the biological effectiveness is related to the 
pattern of energy deposits on the microscopic scale, the so-
called track structure [4]. Clusters of lesions in the DNA 
molecule within site sizes of few nanometers play a 
particular role in this context [4], [5], [6].  
A first approach to measure track structure of ionizing 
radiation with nanometric resolution was proposed already 
in 1975 [7]. However, the extension of microdosimetric 
measurements to site sizes of few nanometer dimension 
was facing the fundamental problem that in such small sites 
the number of interactions is too low, such that the 
assumption fails that the imparted energy is the number of 
ionizations multiplied by a simple conversion factor [8]. 
Therefore, the development of methods for measuring track 
structure details with nanometric resolution required a 
change of paradigm, namely restricting the characterization 
of track structure to its ionization component [9], [10].  
In should be noted in this context that the term 
nanodosimetry is used in the literature in different 
meanings. These include ongoing endeavors to extend 
microdosimetry into the nanometer range to below 100 nm 
site sizes [11], [12] as well as simulation studies of various 
kinds that are not focused on quantities that are directly 
measurable. In this paper we use the term nanodosimetry 
for studies of charged particle track structure, considering 
the stochastics of ionizations in nanometric targets.  
The quantity of interest is the relative frequency 
distribution of the so-called ionization cluster size, i.e. the 
number of ionizations inside a considered target (often 
called the ‘site’). As is illustrated in Figure 1, the ionization 
cluster size distribution (ICSD) varies with the geometrical 
position of the target with respect to the particle track. 
Furthermore, it also depends on the size and composition of 
the target and, most importantly, on the radiation quality. 
The ICSD can also be characterized by its statistical 
moments or the complementary cumulative frequencies of 
ionization clusters exceeding a certain minimum size [13].  
Around the turn of the century, three different types of 
nanodosimeters have been developed to measure the 
frequency distribution of ionization cluster size [14]. All 
devices are gas counters that simulate nanometric sensitive 
volumes based on a density scaling principle [15]. They 
 
Figure 1. Schematic illustration of nanodosimetric ionization cluster size 
(ICS) distributions in a spread-out Bragg peak (SOBP) of protons in 
water. The orange spheres indicate the loci of ionizing interactions of the 
proton or of the emitted secondary electrons. The blue and red cylinders 
represent nanometric targets located in the core and in the penumbra 
region of the track, respectively. The histograms with the blue and red 
columns show the corresponding relative frequency distributions of ICS 
(up to ICS of 8 and 4, respectively) as obtained by Monte Carlo 
simulation with the Geant4-DNA code for target cylinders of 2.3 nm 
diameter and 3.4 nm height. As can be seen, the ICS distributions shift 
towards larger cluster values across the SOBP, where this variation is 
more pronounced in the track core region, indicating a potential rise in 
relative biological effectiveness.  
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differ in the details of their operation principles and in the 
size of the (single) simulated nanometric site [14].  
Within the European project BioQuaRT [16], [17], an 
intercomparison of the three nanodosimeter types was 
conducted for a number of ion types and energies. Despite 
the large differences between the ionization cluster-size 
distributions measured with the three devices for each 
radiation quality (ion type and energy), the parameters of 
the measured distributions were found to follow a universal 
relation (see Fig. 2 in reference [18]). Furthermore, this 
universal relation was also found to reproduce for a number 
of cell lines the dependence on linear energy transfer of the 
effective cross sections for inducing the biological endpoint 
of cell inactivation after ion irradiation (Figs. 4 to 7 in 
[18]).  
In this context, the relevant nanodosimetric parameter 
depends on the repair capacity of the cells and the value of 
absorbed dose, and there is basically only one scaling 
factor between cumulative frequencies and the cross 
sections which turns out to be close to the cell nucleus 
cross sectional area. For details the reader is referred to 
reference [18]. 
In a subsequent work by Conte et al., these finding were 
exploited even further to establish a link between measured 
nanodosimetric parameters of ion track structure and the 
coefficients of the linear-quadratic model for cell survival 
[19]. This progress has stimulated investigations into the 
potential use of nanodosimetric parameters in treatment 
planning, as these offer the advantage of measurable 
quantities linked to the biological outcome of the 
irradiation [20], [21], [22].  
Despite the undeniable and impressive evidence found by 
Conte et al. [18], [19], a major concern that is often raised 
is the implication that radiation interaction with a single 
nanometric target should decide the fate of the irradiated 
cell. It is still an open issue to resolve how these finding 
can be reconciled with the overwhelming evidence of the 
importance of indirect radiation effects (i.e. via radiation 
chemistry) and existing evidence of several relevant scales 
for radiation effectiveness [23]. 
In fact, also the BioQuaRT project developed a multi-
scale model that included microdosimetry and 
nanodosimetry and the possibility of different relevant 
target sizes depending on the biological endpoint 
considered [17]. At least two similar approaches have been 
developed independently by other groups [24], [25]. 
Furthermore, theoretical investigations suggest that 
biological radiation effects originate in the interaction of 
different DNA lesions [26].  
In consequence, respective new developments have been 
started in the field of experimental nanodosimetry that aim 
at measuring the correlations of cluster-size distributions 
induced within a particle track in two separate nanometric 
targets in proximity [27], [28] or at obtaining a 3D image 
of the nanometric particle track structure for track segments 
of few 100 nm in length [29], [30], [31]. The latter would 
to some extent bridge towards microdosimetric 
measurements at the few-hundred nanometer regime [12].  
A recent simulation study by Selva et al. investigated the 
exploitation of the universal nanodosimetric relation [18] in 
radiotherapy by using (still only hypothetical) solid-state 
nanodosimeters that contain multiple targets of nanometric 
site size [32]. In fact, a first attempt at developing such 
nanodosimetric detectors with true nanometric dimensions 
has been recently made by using electrical nano-circuits 
with DNA-based nanowires [33]. Both approaches imply to 
some extent a need for revision of the concepts of 
nanodosimetry [32]. However, this would actually be 
aligned with the presently most advanced approach to using 
nanodosimetry for predicting relative biological 
effectiveness (RBE) in radiotherapy treatment planning, the 
so-called track-event theory of Besserer and Schneider 
[34], [35].  
Although there have also been first approaches applying 
nanodosimetry with brachytherapy photon sources [36], the 
first field where nanodosimetry will be used in treatment 
planning seems to be radiotherapy using protons or ion 
beams. For the latter, the variation of the RBE is already 
accounted for in treatment planning [37], while for protons 
a constant RBE-weighting factor of 1.1 is used and the 
likely RBE variation is accounted for by considering the 
so-called biological range uncertainty [38], [39].  
Several major challenges still have to be mastered before 
nanodosimetric treatment planning will come into routine 
clinical practice. One is the development of nanodosimeters 
that are suited for daily quality assurance measurements on 
a routine basis as opposed to the quite bulky and 
sophisticated instruments used for nanodosimetric 
measurements so far. A second one relates to simulations 
and to the development of methods for fast computation of 
relevant nanodosimetric parameters along the entire 
particle track [40]. Establishing a ‘gold standard’ Monte 
Carlo code for track structure simulations (including the 
chemical and biochemical reactions ensuing the physical 
radiation action) and the experimental validation of its 
entrance data as well as its intermediate results also seems 
a necessity. Eventually, the assessment of the uncertainties 
of nanodosimetric quantities obtained from measurements 
[41] and simulations [42] is of paramount importance.  
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